POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
<p>GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing artificial intelligence ("AI")-enabled healthcare solutions, today announced that it has commenced to terminate its American...</p>
Read original article ↗
Related Articles
Siemens Mobility wins over €2 billion battery train contract
The order includes 113 three-car Mireo Plus B trains, an extensive 30-year service package, and the construction of two
NYU Engineers and Archaeologists Use AI to Piece Together the Past
Schmidt Sciences–backed project will reassemble fragments of stone tools, pottery and bones that have sat unmatched in c
Volvo Cars expands Nvidia partnership for automated driving
Volvo Cars is extending its partnership with Nvidia to develop automated driving for its future cars. The aim is for the
EchoNous unveils Torso NXT, the next evolution of the Kosmos ultrasound platform
Top-tier image quality and AI clinicians trust, in a probe designed for POCUS users by POCUS users REDMOND, Wash., Oct.